Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic Disorders
NCT ID: NCT00455390
Last Updated: 2007-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
330 participants
INTERVENTIONAL
2007-01-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prevention is yet poor, secondary prevention trying to avoid a post traumatic disorder apparition early after the traumatic event. There is currently two types of secondary prevention :
* Mitchell's debriefing based upon stress and its theories, using cognitive and behavioural approaches
* French debriefing (post-immediate psychotherapeutic intervention) based on the traumatism, never realised before second day post event and applied by mental health professionals.
The current controversy of the Mitchell's debriefing leads us to evaluate the post-immediate psychotherapeutic intervention, never evaluated yet.
Scientific Objectives Primary objective: To verify that post-immediate psychotherapeutic interventions (proposed after 2 days and before the end of first month post event) decrease incidence, duration and intensity of psychotraumatic disorders at one year, versus a control group.
Secondary objectives :
* To document the efficacy of these interventions regarding professional, social and familial adaptation.
* To identify predictive factors of response to this strategy.
Method Experimental Design National multicentered, randomized, single blind study Study Population 330 men or women aged 18 to 65, subjected to a potentially traumatic event (criteria A1, DSM IV) and having presented an emotional reaction (intense fear, impotency or horror, criteria A2, DSM IV). This event must have happened within 8 days prior randomization. Patients treated with βblockers and patients suffering from psychopathologic disorders won't be considered for the study.
Outcome measures Primary outcome: PTSD frequency (on the basis of questionnaire CAPS).
Secondary outcome:
* Complete and subsyndormic PTSD occurence (CAPS),
* Intensity of psychotraumatic disorders (Sheehan scale),
* Psychopathologic disorder frequency (CIDI SF),
* Evolution of anxiety/depression (HAD scale),
* Alcoholization frequency (CAGE scale),
* Frequency of somatic adverse events,
* Access to health care (number and types of contacts).
Expected benefits The post-immediate psychotherapeutic intervention shall avoid psychological disorders apparition or improve its symptoms. This would decrease consequences on personal life (social, relational and professional).
The study results will allow a better knowledge of these post traumatic disorders.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group 1: Post-immediate psychotherapeutic intervention, 2 to 3 seances within the first month following the potentially traumatic event. Each intervention last about 45 minutes.
Group 2-control: no psychotherapeutic intervention, only 2 to 3 supporting sessions.
Eligibility criteria:
Inclusion criteria
* men or women aged 18 to 65,
* subjected to a potentially traumatic event (criteria A1, DSM IV),
* having presented an emotional reaction (intense fear, impotency or horror, criteria A2, DSM IV),
* potentially traumatic event happening within 8 days prior randomization.
Non inclusion criteria
* patients treated with βblockers ,
* patients suffering from psychopathologic disorders within 15 days prior randomization (Axe I DSM IV),
* physical injuries avoiding patient's participation to the study,
* hospitalization \> 72 hours post event,
* traumatic event related to a process of victimisation (domestic violences),
* no informed consent signed
Study type:
Randomized, single blind trial on two parallel groups. Randomization stratified on sex and human design.
Number of patients:
330 in 18 clinical centres
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Post-immediate Psychotherapeutic Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subjected to a potentially traumatic event (criteria A1, DSM IV),
* having presented an emotional reaction (intense fear, impotency or horror, criteria A2, DSM IV),
* potentially traumatic event happening within 8 days prior randomization.
Exclusion Criteria
* patients suffering from psychopathologic disorders within 15 days prior randomization (Axe I DSM IV),
* physical injuries avoiding patient's participation to the study,
* hospitalization \> 72 hours post event,
* traumatic event related to a process of victimisation (domestic violences),
* no informed consent
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Francais d'Epidemiologie Psychiatrique
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie PRIETO, MDH
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Edouard Herriot - SAMU
Lyon, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPPI A
Identifier Type: -
Identifier Source: org_study_id